Our award-winning editorial team will go back in time to recap the biggest developments in pharma & medical device packagingRead more...
|U.S. FDA Grants Priority Review to Simeprevir TMC435 for Combination Treatment of Genotype 1 Chronic Hepatitis C Janssen Research & Development, Llc|
|Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures Global Study Advances Upsher-Smith's CNS Pipeline|
|Boehringer Ingelheim responds to FDA warning letter|
|Svelte Drug-Eluting Stent Utilizing New Class of Bioabsorbable Drug Coating Attains 0% Clinically-Driven Events Through 12-Months in First-In-Man Study|
|J&J's Janssen Poised to Continue Driving Growth, Outlines 10+ Potential New Product Filings by 2017|